 - Group 2 -- Patients must not be receiving opioids and must have cancer related neuropathic pain secondary to post-chemotherapy peripheral neuropathy, post-radiation andor post surgical plexopathy, radiculopathy or neuropathy, or post- herpetic neuralgia. 